Metabolomic Study in Exhaled Breath Condensate of Thoracic Surgical Patients
Overview
Acute lung injury (ALI) following thoracic surgery remains a major source of morbidity and mortality after lung resection. One-lung ventilation (OLV) is usually required in thoracic surgery. OLV is also an important predictor of postoperative ALI. Recent laboratory findings suggested that tissue hypoxemia and ischemia / reperfusion injury of the collapsed lungs during OLV is the major cause of lung injury. Exhaled Breath Condensate (EBC), which is the exhalate from breath typically collected by cooling device, contains most molecules found in the airway. Metabolomics refers to systematic and scientific study of chemical processes involving metabolites. This study will collect EBC for metabolomic analysis and aim to elucidate the biochemical reactions during one-lung ventilation and pathological mechanisms of acute lung injury following thoracic surgery.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: March 2018
Detailed Description
Acute lung injury (ALI) following thoracic surgery remains a major source of morbidity and mortality after lung resection. Despite the advancement in both the surgical techniques and the perioperative management, the incidence of postoperative ALI remains remarkable. Risk factors for postoperative lung injury are evident, including preoperative pulmonary function, type of surgical procedure, intraoperative fluid management, one-lung ventilation, and ventilator settings. One-lung ventilation (OLV) is usually required in thoracic surgery. OLV is also an important predictor of postoperative ALI. Recent laboratory findings suggested that tissue hypoxemia and ischemia / reperfusion injury of the collapsed lungs during OLV is the major cause of lung injury. Exhaled Breath Condensate (EBC), which is the exhalate from breath typically collected by cooling device, contains most molecules found in the airway. EBC analysis has potential applications in lung disease, such as severity of airway inflammation in asthmatic patients. Collecting EBC is simple and non-invasive, in contrast to bronchoscopy for lung biopsy or bronchoalveolar lavage. Metabolomics refers to systematic and scientific study of chemical processes involving metabolites. This study will collect EBC from thoracic surgical patients before, during, and after OLV. The investigators will perform metabolomic analysis and aim to elucidate the biochemical reactions during one-lung ventilation and pathological mechanisms of acute lung injury following thoracic surgery.
Interventions
- Procedure: Thoracic Surgery with Lung Resection
- General anesthesia and lung separation Thoracic surgery with lung resection, such as lobectomy, segmentectomy
- Procedure: Thoracic Surgery without Lung Resection
- General anesthesia and lung separation Thoracic surgery without lung resection, such as esophageal surgery, mediastinal surgery
Arms, Groups and Cohorts
- Thoracic Surgery with Lung Resection
- General anesthesia and lung separation Thoracic Surgery with Lung Resection, such as lobectomy, segmentectomy
- Thoracic Surgery without Lung Resection
- General anesthesia and lung separation Thoracic Surgery without Lung Resection, such as esophageal surgery, mediastinal surgery
Clinical Trial Outcome Measures
Primary Measures
- Number of participants with acute lung injury following thoracic surgery
- Time Frame: 30 days
Secondary Measures
- Metabolome of exhaled breath condensate associated with lung injury in thoracic surgery
- Time Frame: 5 hours
Participating in This Clinical Trial
Inclusion Criteria
- Thoracic surgical patients requiring lung isolation – Pulmonary resection: lobectomy, segmentectomy – Esophageal surgery and no pulmonary resection – Mediastinal surgery and no pulmonary resection Exclusion Criteria:
- Metabolic disorder – Metabolic syndrome – Diabetes – Pregnancy
Gender Eligibility: All
Minimum Age: 20 Years
Maximum Age: 80 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- National Taiwan University Hospital
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Ya-Jung Cheng, MD, PhD, Study Chair, National Taiwan University Hospital
- Overall Contact(s)
- Ya-Jung Cheng, MD, PhD, +886-2-23123456, chengyj@ntu.edu.tw
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.